FDA Inspection 1061781 — Northern Illinois Blood Bank Inc.
The FDA completed an inspection of Northern Illinois Blood Bank Inc. on Jul 30, 2018 in Belvidere, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 30, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Belvidere, IL (United States)